
StackAI is an enterprise AI automation platform built to help organizations create end-to-end internal tools and processes with AI agents. Unlike point solutions or one-off chatbots, StackAI provides a single platform where enterprises can design, deploy, and govern AI workflows in a secure, compliant, and fully controlled environment.
Using its visual workflow builder, teams can map entire processes — from data intake and enrichment to decision-making, reporting, and audit trails. Enterprise knowledge bases such as SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected directly, with features for version control, citations, and permissioning to keep information reliable and protected.
AI agents can be deployed in multiple ways: as a chat assistant embedded in daily workflows, an advanced form for structured document-heavy tasks, or an API endpoint connected into existing tools. StackAI integrates natively with Slack, Teams, Salesforce, HubSpot, ServiceNow, Airtable, and more.
Security and compliance are embedded at every layer. The platform supports SSO (Okta, Azure AD, Google), role-based access control, audit logs, data residency, and PII masking. Enterprises can monitor usage, apply cost controls, and test workflows with guardrails and evaluations before production.
StackAI also offers flexible model routing, enabling teams to choose between OpenAI, Anthropic, Google, or local LLMs, with advanced settings to fine-tune parameters and ensure consistent, accurate outputs.
A growing template library speeds deployment with pre-built solutions for Contract Analysis, Support Desk Automation, RFP Response, Investment Memo Generation, and InfoSec Questionnaires.
By replacing fragmented processes with secure, AI-driven workflows, StackAI helps enterprises cut manual work, accelerate decision-making, and empower non-technical teams to build automation that scales across the organization.
Learn more

Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more
Cloudbyz Safety and Pharmacovigilance (PV)
The Cloudbyz Safety & Pharmacovigilance Solution is a cloud-based platform tailored to enhance drug safety and pharmacovigilance for companies in the pharmaceutical and life sciences sectors. This innovative solution automates the entire workflow of data collection, processing, analysis, and reporting in adherence to global regulatory standards.
Cloudbyz offers comprehensive management of the pharmacovigilance lifecycle, encompassing adverse event processing, case management, regulatory reporting, signal detection, and risk management. By utilizing Cloudbyz, organizations can streamline their pharmacovigilance operations, expedite case processing, and boost the precision of their safety data, all while mitigating risks and ensuring compliance with regulations. Additionally, the advantages of our solution include:
1. Enhanced efficiency through automation
2. Improved accuracy of data
3. Immediate visibility into processes
4. Better collaboration among teams
5. Strengthened adherence to regulatory requirements
Furthermore, adopting this solution empowers organizations to focus on innovation and patient safety, ultimately leading to improved outcomes in drug monitoring.
Learn more
DrugCard
DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine safety intelligence workflows, reduce manual screening, and maintain audit-ready pharmacovigilance processes.
The platform supports global and local medical literature monitoring, regulatory intelligence, and adverse event data management in one connected workflow. DrugCard helps PV teams detect relevant safety information faster, review AI-generated article summaries, prioritize safety-relevant publications, translate local sources, create cases from literature, and maintain full traceability across screening and review activities.
DrugCard’s literature monitoring solution covers 121+ countries, 2,200+ local medical sources, and 100+ languages, combining global sources such as PubMed with local, non-indexed journals that are often difficult to monitor manually. The system provides configurable projects, automated monitoring, keyword highlighting, AI pre-assessment of safety relevance, automated reports, notifications, QC workflows, audit trails, and documentation-ready outputs.
In addition to literature monitoring, DrugCard includes AI-powered Regulatory Intelligence for tracking updates from health authorities and an Adverse Event Database for centralized safety data collection, E2B(R2/R3) support, reporting, analytics, and compliant case management.
DrugCard is built for pharmacovigilance teams that need scalable, transparent, and compliant automation while keeping human experts in control of final medical and regulatory decisions.
Learn more